Hemat A Elariny

6PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical devicesPharmaceutical delivery technologiesBiologically active moleculesPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Alogliptin/Amentoflavone Combination Mitigates Bleomycin-Induced Lung Fibrosis: The Role of Oxidative Stress, TXNIP-Mediated Pyroptosis, and Autophagy/Apoptosis Balance.

|Nov 27, 2024
Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer's Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMGB1 Signalling.

Hemat A Elariny, Ahmed M Kabel, Heba Mohammed Refat M Selim

|Sep 27, 2024
Development of Glycerosomal pH Triggered In Situ Gelling System to Ameliorate the Nasal Delivery of Sulpiride for Pediatric Psychosis.

Mona M Shahien, Alia Alshammari, Somaia Ibrahim

|Aug 28, 2024
Plant-Based Nanovesicular Gel Formulations Applied to Skin for Ameliorating the Anti-Inflammatory Efficiency.

Hanan Abdelmawgoud Atia, Mona M Shahien, Somaia Ibrahim

|Apr 26, 2024
The Exploitation of Sodium Deoxycholate-Stabilized Nano-Vesicular Gel for Ameliorating the Antipsychotic Efficiency of Sulpiride.

Marwa H Abdallah, Mona M Shahien, Alia Alshammari

|Nov 07, 2023
Pioglitazone attenuates tamoxifen-induced liver damage in rats via modulating Keap1/Nrf2/HO-1 and SIRT1/Notch1 signaling pathways: In-vivo investigations, and molecular docking analysis.

Gellan Alaa Mohamed Kamel, Hemat A Elariny

Pageof 1

Frequent Collaborators

3 joint publications

Marwa H Abdallah

2 joint publications

Ahmed M Kabel

1 joint publications

Gellan Alaa Mohamed Kamel

1 joint publications

Alia Alshammari